Wird geladen...
The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
OBJECTIVE: Immunological studies have demonstrated a plethora of beneficial effects of dimethyl fumarate (DMF) on various cell types. However, the cellular and molecular targets are incompletely understood and response markers are scarce. Here, we focus on the relation between nuclear factor (erythr...
Gespeichert in:
| Veröffentlicht in: | Ann Clin Transl Neurol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989754/ https://ncbi.nlm.nih.gov/pubmed/29928650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.553 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|